Ian Gourley

Chief Tech/Sci/R&D Officer at IMMUNOVANT, INC.

Health Technology

Consumer Services

Profile

Ian Gourley currently works at The Royal College of Physicians, as Member and Immunovant, Inc., as Vice President-Clinical Development.
Dr. Gourley also formerly worked at Eli Lilly & Co., as Head-Clinical Research Pathologist and Janssen Pharmaceuticals, Inc., as Head-Translational Medical Science.
Dr. Gourley received his graduate degree from Queen's University of Belfast.

Ian Gourley active positions

Companies	Position	Start
IMMUNOVANT, INC.	Chief Tech/Sci/R&D Officer	-
The Royal College of Physicians	Corporate Officer/Principal	-

All active positions of Ian Gourley

Former positions of Ian Gourley

Companies	Position	End
ELI LILLY AND COMPANY	Corporate Officer/Principal	-
Janssen Pharmaceuticals, Inc. Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.	Corporate Officer/Principal	-

See the detail of Ian Gourley's experience

Training of Ian Gourley

Queen's University of Belfast

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ian Gourley's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
IMMUNOVANT, INC.	Health Technology
ELI LILLY AND COMPANY	Health Technology

Private companies	1
Janssen Pharmaceuticals, Inc. Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.	Health Technology